Delivery Order SPE2DB20D2014-SPE2DB25FD02U
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,224.45 to AmerisourceBergen Drug Corp for 180 tablets of Janumet XR 50-1,000 mg on September 16, 2025, with a completion date of September 17, 2025. This competitively awarded, firm fixed-price contract involves pharmaceutical delivery to support federal medical procurement needs. The contract was fulfilled by AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery...
- The Defense Logistics Agency awarded a $17,381.13 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units). The delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of November 7, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order under its capacity as a prime contractor supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,065.75 to AmerisourceBergen Drug Corp for 180-count supplies of Janumet XR 50-1,000 mg tablets. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, ultimately completed on August 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location. This delivery order was issued...
- The Defense Logistics Agency awarded a delivery order valued at $5,169.04 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (60-count units). The contract was competitively awarded without set-aside designation under a firm fixed-price structure, with an ultimate completion date of November 6, 2025. AmerisourceBergen's Conshohocken, Pennsylvania corporate office will serve as the place of performance for this order. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count packages) valued at $3,508.43. This contract utilizes a firm fixed-price structure with an ultimate completion date of September 26, 2025, and was awarded on a competitive basis without any set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Janumet XR 50-1,000 mg tablets (60-count units) with a ceiling value of $19,258.50. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) valued at $3,328.77. This firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a non-competitive delivery against AmerisourceBergen's larger indefinite delivery contract with DLA. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $76,733.23 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed price contract. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $4,370.27 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count units). This firm fixed-price delivery order, awarded on September 2, 2025, with completion targeted for September 3, 2025, represents a routine pharmaceutical procurement executed through open competition with no set-aside designation. The vendor, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its...
- The Defense Logistics Agency awarded a delivery order valued at $4,193.47 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD02UDelivery Order
The Defense Logistics Agency (DLA) awarded a $17,575.18 delivery order to AmerisourceBergen Drug Corp for the supply of Janumet XR 100-1,000 mg tablets (90-count units) under a firm fixed-price contract. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, delivered the pharmaceutical product to its corporate office location, serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. This delivery order represents a task executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates extensive experience fulfilling diverse medical supply requirements across multiple therapeutic domains, positioning it as a key partner in supporting Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.6k | 9/17/25 |